busulfan has been researched along with Viral Diseases in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifty-one patients with acute nonlymphocytic leukemia (16 with end-stage disease, 17 in second or third remission or in early relapse, and 18 in first remission) were given infusions of HLA-identical sibling marrow after cytoreduction with high doses of busulfan and cyclophosphamide." | 7.66 | Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. ( Beschorner, WE; Bias, WB; Braine, HG; Brookmeyer, R; Burns, WH; Elfenbein, GJ; Kaizer, H; Santos, GW; Saral, R; Tutschka, PJ, 1983) |
| "Fifty-one patients with acute nonlymphocytic leukemia (16 with end-stage disease, 17 in second or third remission or in early relapse, and 18 in first remission) were given infusions of HLA-identical sibling marrow after cytoreduction with high doses of busulfan and cyclophosphamide." | 3.66 | Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. ( Beschorner, WE; Bias, WB; Braine, HG; Brookmeyer, R; Burns, WH; Elfenbein, GJ; Kaizer, H; Santos, GW; Saral, R; Tutschka, PJ, 1983) |
| "Such opportunistic viral infections, leading to either interstitial pneumonia or hemorrhagic gastroenteritis, are the major threat in the early recovery phase after engraftment has taken place." | 2.37 | Infections and immunodeficiency in bone marrow transplantation. ( Tutschka, PJ, 1988) |
| "Among the causes of IRM, bacterial infections and IFIs were more common in sCBT (15% vs." | 1.42 | Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH). ( Barba, P; Bautista, G; Cabrera, JR; Duarte, R; Esquirol, A; Fores, R; García, I; García-Marco, JA; Heras, I; Marquez-Malaver, FJ; Martino, R; Parody, R; Regidor, C; Rovira, M; Saavedra, S; Sánchez-Ortega, I; Serrano, D; Sierra, J; Vazquez, L, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lehmberg, K | 1 |
| Albert, MH | 1 |
| Beier, R | 1 |
| Beutel, K | 1 |
| Gruhn, B | 1 |
| Kröger, N | 1 |
| Meisel, R | 1 |
| Schulz, A | 1 |
| Stachel, D | 1 |
| Woessmann, W | 1 |
| Janka, G | 1 |
| Müller, I | 1 |
| Martino, R | 1 |
| Bautista, G | 1 |
| Parody, R | 1 |
| García, I | 1 |
| Esquirol, A | 1 |
| Rovira, M | 1 |
| Cabrera, JR | 1 |
| Regidor, C | 1 |
| Fores, R | 1 |
| García-Marco, JA | 1 |
| Serrano, D | 1 |
| Barba, P | 1 |
| Heras, I | 1 |
| Marquez-Malaver, FJ | 1 |
| Sánchez-Ortega, I | 1 |
| Duarte, R | 1 |
| Saavedra, S | 1 |
| Sierra, J | 1 |
| Vazquez, L | 1 |
| Satwani, P | 1 |
| Baldinger, L | 1 |
| Freedman, J | 1 |
| Jacobson, JS | 1 |
| Guerra, J | 1 |
| van de Ven, C | 1 |
| Morris, E | 1 |
| Garvin, J | 1 |
| George, D | 1 |
| Bradley, MB | 1 |
| Bhatia, M | 1 |
| Tallamy, B | 1 |
| Schwartz, J | 1 |
| Jin, Z | 1 |
| Cairo, MS | 1 |
| MARSDEN, HB | 1 |
| STEWARD, JK | 1 |
| Chen, J | 1 |
| Santos, GW | 1 |
| Tutschka, PJ | 3 |
| Brookmeyer, R | 1 |
| Saral, R | 1 |
| Beschorner, WE | 2 |
| Bias, WB | 1 |
| Braine, HG | 1 |
| Burns, WH | 1 |
| Elfenbein, GJ | 1 |
| Kaizer, H | 1 |
3 reviews available for busulfan and Viral Diseases
| Article | Year |
|---|---|
Animal models for acquired bone marrow failure syndromes.
Topics: Anemia, Aplastic; Animals; Benzene; Bone Marrow Diseases; Busulfan; Chloramphenicol; Disease Models, | 2005 |
Destruction of the intestinal mucosa after bone marrow transplantation and graft-versus-host disease.
Topics: Acute Disease; Bone Marrow Transplantation; Busulfan; Chronic Disease; Combined Modality Therapy; Cy | 1984 |
Infections and immunodeficiency in bone marrow transplantation.
Topics: Anti-Bacterial Agents; Bacterial Infections; Bone Marrow Transplantation; Busulfan; Graft vs Host Di | 1988 |
6 other studies available for busulfan and Viral Diseases
| Article | Year |
|---|---|
Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Busulfan; Child; Child, Preschool; Female; Graft Surv | 2014 |
Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH).
Topics: Adolescent; Adult; Antigens, CD34; Bacterial Infections; Busulfan; Cohort Studies; Cord Blood Stem C | 2015 |
Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients.
Topics: Busulfan; Child; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Kaplan-Meier Es | 2009 |
LEUKAEMIA IN CHILDREN.
Topics: Adolescent; Black People; Bone Marrow Examination; Busulfan; Child; Chromosome Aberrations; Cyclopho | 1965 |
Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Bone Marrow Transplantation; Busulfan; Child; Combine | 1983 |
Diminishing morbidity and mortality of bone marrow transplantation.
Topics: Administration, Oral; Bone Marrow Transplantation; Busulfan; Combined Modality Therapy; Cyclophospha | 1986 |